These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7911745)
21. Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations. Johnson M; Bush LG; Hanson GR; Gibb JW Biochem Pharmacol; 1993 Aug; 46(4):770-2. PubMed ID: 8103327 [TBL] [Abstract][Full Text] [Related]
22. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938 [TBL] [Abstract][Full Text] [Related]
24. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices. Fitzgerald JL; Reid JJ Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569 [TBL] [Abstract][Full Text] [Related]
25. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain. Hashimoto K; Maeda H; Goromaru T Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935 [TBL] [Abstract][Full Text] [Related]
26. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
27. 5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat brain synaptosomes. Park WK; Azmitia EC Ann N Y Acad Sci; 1991; 635():438-40. PubMed ID: 1683755 [No Abstract] [Full Text] [Related]
28. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Leonardi ET; Azmitia EC Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733 [TBL] [Abstract][Full Text] [Related]
29. Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Gobbi M; Frittoli E; Uslenghi A; Mennini T Eur J Pharmacol; 1993 Jul; 238(1):9-17. PubMed ID: 8405087 [TBL] [Abstract][Full Text] [Related]
30. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan. Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220 [TBL] [Abstract][Full Text] [Related]
31. Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat. Piercey MF; Lum JT; Palmer JR Brain Res; 1990 Sep; 526(2):203-6. PubMed ID: 1979517 [TBL] [Abstract][Full Text] [Related]
32. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]
33. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Rattray M Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707 [No Abstract] [Full Text] [Related]
34. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system. Pan HS; Wang RY Brain Res; 1991 Mar; 543(1):56-60. PubMed ID: 1675924 [TBL] [Abstract][Full Text] [Related]
36. Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. Schaefer TL; Ehrman LA; Gudelsky GA; Vorhees CV; Williams MT J Neurochem; 2006 Sep; 98(5):1369-78. PubMed ID: 16923155 [TBL] [Abstract][Full Text] [Related]
38. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Stone DM; Stahl DC; Hanson GR; Gibb JW Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893 [TBL] [Abstract][Full Text] [Related]
39. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
40. In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine. Murphy J; Flynn JJ; Cannon DM; Guiry PJ; McCormack P; Baird AW; McBean GJ; Keenan AK Eur J Pharmacol; 2002 May; 444(1-2):61-7. PubMed ID: 12191583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]